Kuano simulation and modelling platform
Kuano’s proprietary platform: Unique synergy of quantum methods, large-scale simulations, and computational chemistry
Kuano combines advanced quantum techniques with large-scale simulations to accelerate drug discovery. Our platform integrates automated QM, MD, and QMMM simulations, alongside methods such as FEP, MMPBSA, SAPT, FMO, DFT, and DMRG, enabling rapid exploration of drug-like chemical space.
Fast and effective
Rapidly explore new areas of chemical space with a suite of solutions including reaction-informed GNNs, RNNs, active learning, and genetic algorithms, guided by both data-driven and physics-based objectives.
More than a tool
Our fully-integrated design engine combines AI and physics-based models, with visualization and reporting accessible to non-specialists. Deep science experts collaborate directly with you to maximize insights and results.
Proven track record
Kuano addresses challenging ‘undruggable’ targets, including selectivity, phosphatases, metalloproteases, and more. We deliver real-world drug programs from HitID to Lead Optimization, including transition-state drug design, and can evaluate and scale solutions across multiple targets.
Posters
We believe that the future of drug discovery lies at the intersection of advanced computation and deep scientific insight. Our team is committed to presenting our latest advancements at leading scientific conferences, driving forward the fields of AI in chemistry and simulation and drug target analysis.
Explore the posters we have presented, which showcase how our proprietary technology is leveraging simulation, quantum chemistry, and artificial intelligence to accelerate the identification and optimization of novel therapeutic compounds.